Omron Healthcare is acquiring Matsusha R&D through a tender offer to stabilize its supply chain for critical health device components and enhance product innovation.
Target Information
Omron Healthcare, a subsidiary of Omron Corporation (ticker: 6645), is based in Fukuchiyama City, Kyoto Prefecture, and specializes in the manufacture and sale of health devices, including thermometers and blood pressure monitors. As competition in the blood pressure monitor market intensifies, there has been a noticeable shift in demand toward mid to low price ranges. Omron Healthcare has identified the need to ensure a stable supply of essential components, particularly the cuffs, which significantly affect the accuracy and quality of blood pressure monitors.
To address this, Omron Healthcare is acquiring Matsusha R&D (ticker: 7317) through a tender offer, thus securing a direct supply of these critical components. This acquisition aims not only to stabilize supply but also to expedite new product development and reduce production costs.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Japan
The health device market in Japan is characterized by rapid technological advancements and growing consumer awareness about health management. With an aging population, there is an increasing
Similar Deals
Carlyle Group → HOGY Medical
2025
Advantage Partners (AP) and LYFE Capital Investment Management Ltd. → Nihon Chouzai Co., Ltd.
2025
Tokyo University Co-Creation Platform Development Co., Ltd. → Heartseed Inc.
2024
San Holdings → Kizuna Holdings
2023
Omron Healthcare
invested in
Matsuya R&D
in 2025
in a Public-to-Private (P2P) deal
Disclosed details
Transaction Size: $2,050M